We are happy to announce that Murinus has joined forces with the service provider genOway, the European Market Leader in the field of transgenesis. Murinus' business will be continued under the name genOway Germany GmbH and will still be based in Hamburg. Please see the following press release for further information: Press release.
This merger will provide customers with an extended service portfolio:
You have now additional access to:
•
validated technologies for in vivo RNAi-based gene knock-down (Safe in vivo RNAi™)
•
shorter development times of knock-in models using validated ready-to-use targeting vectors (Quick Knock-in™ technology)
•
ready-to-use cassettes (positive, negative selection, loxP-, FRT-flanked, reporter constructs) for your own targeting vector construction
•
a range of well-characterised deleter strains for in vivo excision
You can now start your transgenic project without any need for an animal license application (Tierversuchsantrag). genOway has a general animal experimentation license and does not have to apply for each new project. This will enable the development time to be reduced by at least 4 weeks.
The animal facility of genOway is entirely subcontracted to Charles River Laboratories. Breeding is performed under SPF / SOPF conditions. This unique partnership provides the following benefits:
•
Worldwide delivery of SPF / SOPF certified animals by using the CRL logistic network
•
Entire control of the genetic background lineage
•
No re-derivation needed to enter customer's barrier facility or CRL Filter Top Cages breeding units
